Open Access
Safety and efficacy ofHansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
World Journal Of GastroenterologyPeer ReviewedSuzan El Naghi2014Journals
To investigate the safety and efficacy of a Hansenula-derived PEGylated (polyethylene glycol) interferon (IFN)-alpha-2a (Reiferon Retard) plus ribavirin customized regimen in treatment-naïve and previously treated (non-responders and relapsers) Egyptian children with chronic hepatitis C infection.

The content you want is available to Zendy users.

Already have an account? Sign in
Having issues? Contact support